IDEXX LABORATORIES INC /DE (IDXX) Free cash flow 2016–2025
IDEXX LABORATORIES INC /DE (IDXX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.1BFY2025 · since FY2016: $274.2M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +30.8% |
| FY2024 | $808.1M | +4.6% |
| FY2023 | $772.9M | +96.1% |
| FY2022 | $394.1M | -38.0% |
| FY2021 | $636.0M | +17.5% |
| FY2020 | $541.1M | +77.9% |
| FY2019 | $304.2M | +7.0% |
| FY2018 | $284.3M | -4.9% |
| FY2017 | $298.9M | +9.0% |
| FY2016 | $274.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IDXX financial trends
IDXX RevenueIDXX Net incomeIDXX Net marginIDXX Gross profitIDXX Gross marginIDXX Operating incomeIDXX Operating marginIDXX Operating cash flowIDXX Capital expendituresIDXX Return on equityIDXX Stock buybacksIDXX Dividends paidIDXX Total assetsIDXX Total liabilitiesIDXX Shareholders’ equityIDXX overview →